NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | ![]() Dare Bioscience Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 2009 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Gaithersburg, US HQ | Locations West Lake Hills, US HQ Austin, US | Locations San Diego, US HQ |
Employees | Employees 5032% decrease | Employees 2865% increase | Employees 980% increase |
Valuation ($) | Valuation ($) 372.4 k | Valuation ($) 6.3 m | Valuation ($) 33.8 m |
Financial | |||
Net income | Net income ($32.3m) (FY, 2023) | Net income ($16.2m) (FY, 2025) | Net income ($13.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 33.8m | Total funding raised N/A | Total funding raised $ 115.7m |
Genprex is a gene therapy company developing treatments for cancer and diabetes.
View company
Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
View company